Search Results for "Azelastine Hydrochloride Ophthalmic Solution0 05"
Matching Channels
Erectile dysfunction (ED or impotence) is the inability to get and maintain an erection that is sufficient for satisfactory sexual intercourse, and affects half of all men between the ages of 40 to...
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles'...
Trigeminal Neuralgia (TN) is an extremely severe facial pain that tends to come and go unpredictably in sudden shock-like attacks. The pain is often described as stabbing, shooting, excruciating, bu...
Tumor Necrosis Factor TNF Products
Tumor Necrosis Factor (TNF) and TNF receptor antagonists and agonists used to treat TNF-mediated inflammatory diseases such as rheumatoid arthritis or to treat cancer. TNF blockers are the commerc...
Cytokine Tumour Necrosis Factor (TNF)
TNF is a compound that is classified as a cytokine which plays a central role in the cellular mechanisms of apoptosis or cell death. However, there are a number of different kinds of TNF, just under...
Matching News
Tigard, OR (PRWEB) March 22, 2013 Paragon BioTeck, Inc., a privately held biopharmaceutical company specializing in the development of ophthalmic pharmaceuticals and therapies, today announced that...
New hayfever treatment launched
A novel nasal spray formulation of fluticasone propionate and azelastine hydrochloride has been launched in the UK for relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis...
Meda Dymista now available on prescription in UK
Meda Pharmaceuticals has announced the availability of nasal spray formulation of fluticasone propionate and azelastine hydrochloride, Dymista, on prescription in the UK.
Sun Pharmaceutical gains FDA approval for Azelastine HCL nasal spray
Sun Pharmaceutical Industries has received FDA approval for its abbreviated new drug application (ANDA) of Azelastine HCL nasal spray, 0.1% (137mcg/spray).
Meda's Dymista approved in UK, ready for hay fever season
The UK's regulatory agency has granted marketing authorization for Meda's Dymista, a nasal formulation of fluticasone propionate and azelastine hydrochloride, for the treatment of moderate to severe s...
Meda's Dymista approved for allergic rhinitis
Meda AB (SSE:MEDAA) said its Dymista azelastine/fluticasone was approved under the EU's decentralized procedure to treat seasonal and perennial allergic rhinitis. Germany acted as the reference member...
Cystaran cysteamine hydrochloride ophthalmic solution regulatory update
Matching PubMed Articles
BACKGROUND: A proof-of-concept study suggested that combination therapy with commercial azelastine hydrochloride nasal spray and fluticasone propionate nasal spray significantly improved nasal symptom...
Eudragit RL100 based microspheres for ocular administration of azelastine hydrochloride.
In the present study, potential of polymeric microspheres for treatment of allergic conjunctivitis was investigated. Azelastine hydrochloride loaded Eudragit RL100 microspheres were prepared by solven...
In this study, we investigated a simple, sensitive and reliable liquid chromatography-fluorescence detection method for the determination of memantine hydrochloride in rat plasma which was based on de...
Intra-arterial infusion of chemotherapy into the ophthalmic artery for treatment of retinoblastoma has been realized after catheterization of the internal carotid and temporary balloon occlusion beyon...
Impact of four loci on serum tamsulosin hydrochloride concentration.
Tamsulosin hydrochloride is one of the most potent drugs for treatment of benign prostatic hyperplasia (BPH), however, the efficacy of tamsulosin hydrochloride varies among individuals. In this study,...
